CD 130 (Ranitidine hydrochloride 300 mg)

Pill imprint CD 130 has been identified as Ranitidine hydrochloride 300 mg.

Ranitidine is used in the treatment of gerd; zollinger-ellison syndrome; erosive esophagitis; duodenal ulcer; eczema (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 300 mg is not a controlled substance under the Controlled Substance Act (CSA).

Ranitidine hydrochloride

Imprint:

CD 130

Strength:

300 mg

Color:

Brown

Shape:

Capsule-shape

Availability:

Rx and/or OTC

Drug Class:

H2 antagonists

Pregnancy Category:

B - No proven risk in humans

CSA Schedule:

Not a controlled drug

Manufacturer:

Dr. Reddy’s Laboratories Inc.

National Drug Code (NDC):

55111-0130

Inactive Ingredients:

magnesium stearate
microcrystalline cellulose
sodium starch glycolate type A potato
ferrosoferric oxide
ferric oxide red
ferric oxide yellow
titanium dioxide
gelatin

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.